1-4 of 4
Othman S. Akhtar, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with Relapsed Mantle Cell Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis

Yazeed Sawalha, MD, Subir Goyal, PhD, Jeffrey M. Switchenko, PhD MS, Jason T. Romancik, MD, Manali Kamdar, MD, Irl Brian Greenwell, MD, Brian T. Hess, MD, Krista Isaac, DO,MS, Craig A. Portell, MD, Alex V. Mejia Garcia, MD, Scott R. Goldsmith, MD, Natalie S Grover, MD, Peter A. Riedell, MD, Reem Karmali, MDMSc, Madelyn Burkart, MD, Michael J Buege, PharmD, Othman S. Akhtar, MD, Pallawi Torka, MD, Anita Kumar, MD, Brian T. Hill, MD, Brad S. Kahl, MD, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–6.
https://doi.org/10.1182/blood-2020-138878
Published: 2020
Journal Articles

Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies

Anthony R. Mato, MDMSCE, Lindsey E. Roeker, MD, Toby A. Eyre, MBBChir, MRCP, Ryan Jacobs, MD, Brian T. Hill, MD, Nicole Lamanna, MD, Danielle M. Brander, MD, Mazyar Shadman, MD, Chaitra Ujjani, MD, Maryam Yazdy, MD, Guilherme Fleury Perini, MD, Javier Pinilla Ibarz, MD PhD, Jacqueline C Barrientos, MD, Alan Skarbnik, MD, Pallawi Torka, MD, Jeffrey J Pu, MD PhD, John M. Pagel, MD PhD DSc, Satyen Gohil, BSc, MBBS, MRCP, FRCPath, Bita Fakhri, MDMPH, Michael Y. Choi, MD, Catherine C. Coombs, MD, Joanna Rhodes, MD, Paul M. Barr, MD, Craig A. Portell, MD, Helen Parry, MB ChB, MRCP, PhD, Christine Ann Garcia, MD MPH, Kate J Whitaker, BA, Allison M. Winter, MD, Andrea Sitlinger, MD, Sirin Khajavian, MD, Ariel F Grajales-Cruz, MD, Krista Isaac, DO, MS, Pratik Shah, Othman S. Akhtar, MD, Rachael Pocock, MD, Kentson Lam, MD PhD, Timothy J Voorhees, MD, Stephen J. Schuster, MD, Thomas David Rodgers, MD, Nicolas Martinez-Calle, MD MSc, Talha Munir, MD, Erica B Bhavsar, BS, Neil Bailey, MSc, Jason C. Lee, MD, Hanna Weissbrot, BS, Chadi Nabhan, MDMBA, FACP, Julie Goodfriend, Amber C. King, PharmD, BCOP, Andrew D. Zelenetz, MD PhD, Colleen Dorsey, BSN, RN, Kayla Bigelow, Bruce D. Cheson, MD, Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, John N. Allan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 502.
https://doi.org/10.1182/blood-2019-123747
Published: 2019
Journal Articles

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Othman S. Akhtar, MD, Kris Attwood, PhD MS, Ian Lund, PA-C, Ryan Hare, PharmD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5567.
https://doi.org/10.1182/blood-2018-99-112334
Published: 2018
Journal Articles

Disease Progression on Ibrutinib Therapy Is Associated with a Poor Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Managed in Standard Clinical Practice

Othman S. Akhtar, MD, Pallawi Torka, MD, Seema A. Bhat, MD, Ryan Hare, Sheila N. J. Sait, PhD, AnneMarie W. Block, PhD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5350.
https://doi.org/10.1182/blood.V130.Suppl_1.5350.5350
Published: 2017